# Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

> **NCT03442751** · PHASE3 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 201 (actual)

## Conditions studied

- Progressive Keratoconus

## Interventions

- **DRUG:** Test Article A
- **DRUG:** Test Article B
- **DRUG:** Placebo
- **DEVICE:** KXL medical device system
- **DEVICE:** KXL medical device system

## Key facts

- **NCT ID:** NCT03442751
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-06
- **Primary completion:** 2019-11-01
- **Final completion:** 2020-08-10
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03442751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03442751, "Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03442751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*